# The Preventive Effect of Helicobacter Pylori Eradication on the Development of Gastric Cancer

> **NCT00596401** · — · COMPLETED · sponsor: **Showa Inan General Hospital** · enrollment: 3000 (actual)

## Conditions studied

- Helicobacter Pylori
- Eradication
- Gastric Cancer
- Medical Care Cost

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00596401
- **Lead sponsor:** Showa Inan General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 3000 (ACTUAL)
- **Last updated:** 2022-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00596401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00596401, "The Preventive Effect of Helicobacter Pylori Eradication on the Development of Gastric Cancer". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00596401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*